Literature DB >> 533268

Effect of cefamandole nafate on blood coagulation and platelet function.

G M Custer, B R Briggs, R E Smith.   

Abstract

Platelet function and coagulation were tested after brief in vivo exposure to cefamandole nafate and in the presence of various concentrations of the drug in vitro. Alterations in hemostatic function were observed only with exposure to drug concentrations severalfold higher than those expected to prevail clinically.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 533268      PMCID： PMC352969          DOI： 10.1128/AAC.16.6.869

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  EFFECT OF ADENOSINE NUCLEOTIDES ON PLATELET AGGREGATION AND CLOTTING TIME.

Authors:  J F MUSTARD; B HEGARDT; H C ROWSELL; R L MACMILLAN
Journal:  J Lab Clin Med       Date:  1964-10

2.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

3.  A study of the plasma thrombin time.

Authors:  R T JIM
Journal:  J Lab Clin Med       Date:  1957-07

4.  The effect of citrate on euglobulin methods of estimating fibrinolytic activity.

Authors:  M BUCKELL
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

5.  Morphology and enumeration of human blood platelets.

Authors:  G BRECHER; E P CRONKITE
Journal:  J Appl Physiol       Date:  1950-12       Impact factor: 3.531

6.  Effects of some antibiotics of platelet function in vitro and in vivo.

Authors:  H Johnsson; P M Niklasson
Journal:  Thromb Res       Date:  1977-08       Impact factor: 3.944

7.  The hemostatic defect produced by carbenicillin.

Authors:  C H Brown; E A Natelson; W Bradshaw; T W Williams; C P Alfrey
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

8.  Letter: Coagulopathy with cefazolin in uremia.

Authors:  P I Lerner; A Lubin
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

9.  Cefamandole: in vitro and clinical pharmacokinetics.

Authors:  R S Griffith; H R Black; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

10.  Observations in man on some pharmacologic features of cefamandole.

Authors:  W E Grose; G P Bodey; D Stewart
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875
View more
  3 in total

1.  Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.

Authors:  J C Engle; P W Lifland; C J Schleupner
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

2.  The influence of prophylactic antibiotics on the warfarin anticoagulation response in the postoperative prosthetic cardiac valve patient. Cefamandole versus vancomycin.

Authors:  D M Angaran; V C Dias; K V Arom; W F Northrup; T E Kersten; W G Lindsay; D M Nicoloff
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

3.  Nafcillin-induced platelet dysfunction and bleeding.

Authors:  D P Alexander; M E Russo; D E Fohrman; G Rothstein
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.